[1]
Ho LT, Sprague SM. Renal osteodystrophy in chronic renal failure. Seminars in nephrology. 2002 Nov:22(6):488-93
[PubMed PMID: 12430093]
[2]
Legg V. Complications of chronic kidney disease: a close look at renal osteodystrophy, nutritional disturbances, and inflammation. The American journal of nursing. 2005 Jun:105(6):40-9; quiz 50
[PubMed PMID: 15930868]
[3]
Slatopolsky E, Gonzalez E, Martin K. Pathogenesis and treatment of renal osteodystrophy. Blood purification. 2003:21(4-5):318-26
[PubMed PMID: 12944733]
[4]
Hruska KA, Teitelbaum SL. Renal osteodystrophy. The New England journal of medicine. 1995 Jul 20:333(3):166-74
[PubMed PMID: 7791820]
[5]
Elder G. Pathophysiology and recent advances in the management of renal osteodystrophy. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2002 Dec:17(12):2094-105
[PubMed PMID: 12469904]
Level 3 (low-level) evidence
[6]
Brandenburg VM, Floege J. Adynamic bone disease-bone and beyond. NDT plus. 2008 Jun:1(3):135-47. doi: 10.1093/ndtplus/sfn040. Epub
[PubMed PMID: 25983860]
[7]
Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney international. 1990 Jun:37(6):1522-7
[PubMed PMID: 2194068]
[8]
Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L, Bone Turnover Work Group. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 Mar:43(3):558-65
[PubMed PMID: 14981615]
[9]
Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney international. 1994 Oct:46(4):1160-6
[PubMed PMID: 7861712]
[10]
Eriksen EF. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocrine reviews. 1986 Nov:7(4):379-408
[PubMed PMID: 3536460]
[11]
Aubin JE. Advances in the osteoblast lineage. Biochemistry and cell biology = Biochimie et biologie cellulaire. 1998:76(6):899-910
[PubMed PMID: 10392704]
Level 3 (low-level) evidence
[13]
Piraino B, Chen T, Cooperstein L, Segre G, Puschett J. Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clinical nephrology. 1988 Aug:30(2):57-62
[PubMed PMID: 3180516]
[15]
Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney international. 1994 Sep:46(3):855-61
[PubMed PMID: 7996807]
[16]
Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN. Arterial disease in chronic kidney disease. Heart (British Cardiac Society). 2013 Mar:99(6):365-72. doi: 10.1136/heartjnl-2012-302818. Epub 2012 Oct 31
[PubMed PMID: 23118349]
[17]
Schwarz C, Sulzbacher I, Oberbauer R. Diagnosis of renal osteodystrophy. European journal of clinical investigation. 2006 Aug:36 Suppl 2():13-22
[PubMed PMID: 16884394]
[18]
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003 Oct:42(4 Suppl 3):S1-201
[PubMed PMID: 14520607]
Level 2 (mid-level) evidence
[19]
Messa P, Macário F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazão JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Wilkie M, Zani VJ, Molemans B, Carter D, Locatelli F. The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism. Clinical journal of the American Society of Nephrology : CJASN. 2008 Jan:3(1):36-45. doi: 10.2215/CJN.03591006. Epub
[PubMed PMID: 18178780]
[20]
Moorthi RN, Armstrong CL, Janda K, Ponsler-Sipes K, Asplin JR, Moe SM. The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. American journal of nephrology. 2014:40(6):582-91. doi: 10.1159/000371498. Epub 2015 Jan 20
[PubMed PMID: 25613675]
[21]
Ferreira A, Frazão JM, Monier-Faugere MC, Gil C, Galvao J, Oliveira C, Baldaia J, Rodrigues I, Santos C, Ribeiro S, Hoenger RM, Duggal A, Malluche HH, Sevelamer Study Group. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. Journal of the American Society of Nephrology : JASN. 2008 Feb:19(2):405-12. doi: 10.1681/ASN.2006101089. Epub 2008 Jan 16
[PubMed PMID: 18199805]
[22]
London GM. Bone-vascular axis in chronic kidney disease: a reality? Clinical journal of the American Society of Nephrology : CJASN. 2009 Feb:4(2):254-7. doi: 10.2215/CJN.06661208. Epub 2009 Jan 28
[PubMed PMID: 19176792]
[23]
Bicknell JM, Lim AC, Raroque HG Jr, Tzamaloukas AH. Carpal tunnel syndrome, subclinical median mononeuropathy, and peripheral polyneuropathy: common early complications of chronic peritoneal dialysis and hemodialysis. Archives of physical medicine and rehabilitation. 1991 May:72(6):378-81
[PubMed PMID: 1647756]
[24]
Li C, Chen XM, Li Y, Zhou YL, Yan JN, Du XG. Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients. Kidney diseases (Basel, Switzerland). 2019 Mar:5(2):118-125. doi: 10.1159/000494924. Epub 2019 Feb 6
[PubMed PMID: 31019925]
[25]
Aparicio M, Lafage MH, Combe C, de Precigout V, Bouchet JL, Potaux L. Low-protein diet and renal osteodystrophy. Nephron. 1991:58(2):250-2
[PubMed PMID: 1865990]
[26]
Bonomini V, Mioli V, Albertazzi A, Scolari P. Daily-dialysis programme: indications and results. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1998 Nov:13(11):2774-7; discussion 2777-8
[PubMed PMID: 9829478]
[27]
Ghimire S, Lee K, Jose MD, Castelino RL, Zaidi STR. Adherence assessment practices in haemodialysis settings: A qualitative exploration of nurses and pharmacists' perspectives. Journal of clinical nursing. 2019 Jun:28(11-12):2197-2205. doi: 10.1111/jocn.14821. Epub 2019 Mar 12
[PubMed PMID: 30786082]
Level 2 (mid-level) evidence
[28]
Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H. The burden of kidney disease: improving global outcomes. Kidney international. 2004 Oct:66(4):1310-4
[PubMed PMID: 15458424]
[29]
Viegas C, Araújo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging. 2019 Jun 26:11(12):4274-4299. doi: 10.18632/aging.102046. Epub
[PubMed PMID: 31241466]
[30]
Ketteler M, Gross ML, Ritz E. Calcification and cardiovascular problems in renal failure. Kidney international. Supplement. 2005 Apr:(94):S120-7
[PubMed PMID: 15752228]
[31]
London GM, Marchais SJ, Guérin AP, Métivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Current opinion in nephrology and hypertension. 2005 Nov:14(6):525-31
[PubMed PMID: 16205470]
Level 3 (low-level) evidence
[32]
Kemper MJ, van Husen M. Renal osteodystrophy in children: pathogenesis, diagnosis and treatment. Current opinion in pediatrics. 2014 Apr:26(2):180-6. doi: 10.1097/MOP.0000000000000061. Epub
[PubMed PMID: 24553631]
Level 3 (low-level) evidence
[33]
Esfahani DR, Alaraj A, Birk DM, Thulborn KR, Charbel FT. Stenosis Before Thrombosis: Intracranial Hypertension from Jugular Foramen Stenosis Secondary to Renal Osteodystrophy. World neurosurgery. 2018 Jan:109():129-133. doi: 10.1016/j.wneu.2017.09.106. Epub 2017 Sep 23
[PubMed PMID: 28951273]
[34]
Donoso-Hofer F, Gunther-Wood M, Romero-Romano P, Pezoa-Opazo N, Fernández-Toro MA, Ortega-Pinto AV. Uremic leontiasis ossea, a rare presentation of severe renal osteodystrophy secondary to hyperparathyroidism. Journal of stomatology, oral and maxillofacial surgery. 2018 Feb:119(1):56-60. doi: 10.1016/j.jormas.2017.10.006. Epub 2017 Oct 14
[PubMed PMID: 29037869]
[35]
Meng L, Fu B. Practical use of sevelamer in chronic kidney disease patients on dialysis in People's Republic of China. Therapeutics and clinical risk management. 2015:11():705-12. doi: 10.2147/TCRM.S64657. Epub 2015 Apr 30
[PubMed PMID: 25995642]
[36]
Lopes ML, Albuquerque AF, Germano AR, Queiroz LM, Miguel MC, da Silveira ÉJ. Severe maxillofacial renal osteodystrophy in two patients with chronic kidney disease. Oral and maxillofacial surgery. 2015 Sep:19(3):321-7. doi: 10.1007/s10006-015-0490-9. Epub 2015 Mar 19
[PubMed PMID: 25784153]